Intravitreal sustained-release ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation

Acta Ophthalmologica Scandinavica

Volumn 80, Issue 1, 2002, Pages 101-104

  Ghosh, Fredrik ^a   Hansson, Lars Jörgen ^a   Bynke, Gunnel ^a   Békássy, Albert N ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute lymphoblastic leukemia (ALL); Bone marrow transplant (BMT); Immune reconstitution; Immunosuppression; Stem cell transplantation (SCT); Vitreoretinal surgery

Indexed keywords

ANTIVIRUS AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FOSCARNET; GANCICLOVIR;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG IMPLANT; DRUG SAFETY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; LUNG FUNCTION; LUNG INFECTION; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINITIS; VISUAL ACUITY;

ADOLESCENT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; DRUG IMPLANTS; GANCICLOVIR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSION; LEUKEMIA, LYMPHOCYTIC, ACUTE; LUNG; MALE; PNEUMONIA, VIRAL; VITREOUS BODY;

EID: 0036250164     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2002.800121.x     Document Type: Article

References (12)

1. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir
2. Ganciclovir intraocular implant. A clinicopathologic study
3. Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation
4. Ocular manifestations of HIV infection
5. Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: Prevalence, natural history, and response to ganciclovir therapy
6. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation
7. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial
8. Use of thegan-ciclovir implant for treating cytomegalovirus retinitis secondary to immunosuppression after bone marrow transplantation
9. Replacing ganciclovir implants
10. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus
11. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device
12. High-dose (2000 - Microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis